Bioceltix (WAR:BCX) Price-to-Tangible-Book : 13.52 (As of May. 21, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Bioceltix Price-to-Tangible-Book?

As of today (2025-05-21), Bioceltix's share price is zł113.80. Bioceltix's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was zł8.42. Hence, Bioceltix's Price to Tangible Book Ratio of today is 13.52.

The historical rank and industry rank for Bioceltix's Price-to-Tangible-Book or its related term are showing as below:

WAR:BCX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7 Med: 29.22 Max: 73.86
Current: 13.52

During the past 5 years, Bioceltix's highest Price to Tangible Book Ratio was 73.86. The lowest was 7.00. And the median was 29.22.

WAR:BCX's Price-to-Tangible-Book is ranked worse than
89.28% of 1203 companies
in the Biotechnology industry
Industry Median: 2.72 vs WAR:BCX: 13.52

A closely related ratio is called PB Ratio. As of today, Bioceltix's share price is zł113.80. Bioceltix's Book Value per Sharefor the quarter that ended in Sep. 2024 was zł8.42. Hence, Bioceltix's P/B Ratio of today is 13.52.

Bioceltix Price-to-Tangible-Book Historical Data

The historical data trend for Bioceltix's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioceltix Price-to-Tangible-Book Chart

Bioceltix Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

28.60

25.82

35.50

Bioceltix Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Tangible-Book	Get a 7-Day Free Trial													17.81	35.50	54.05	7.00	8.03

Competitive Comparison of Bioceltix's Price-to-Tangible-Book

For the Biotechnology subindustry, Bioceltix's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioceltix's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioceltix's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Bioceltix's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Bioceltix Price-to-Tangible-Book Calculation

Bioceltix's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2024 )
	=	113.80	/	8.415
	=	13.52

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Bioceltix Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Bioceltix's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioceltix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

XI3:Germany

Address

Bierutowska 57-59 Street, Wroclaw, POL, 51-317

Website

https://www.bioceltix.com

Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.